Founder, Interim CEO & Executive Co-Chairman of the Board
Mr. Durkacz is the “D” in FSD. Mr. Durkacz has served as a director and the Executive Vice-President of First Republic Capital Corporation since 2014. Prior to co-founding the Company, Mr. Durkacz was President of Capital Ideas Investor Relations. He previously served as the Chief Financial Officer and a director of Snipp Interactive Inc., a global marketing solutions company that provides a modular software-as-a-service technology suite. Mr. Durkacz was instrumental in the financing and public listing of Snipp Interactive Inc. with operations in Canada, the United States of America, Mexico and India. From 2006 to 2009, he served as Chief Operating Officer and Chief Financial Officer of MKU Canada Inc. and engaged in mergers and acquisitions of companies around the world. Mr. Durkacz also served as the Chief Financial Officer and a director of Astris Energi Inc., a dual-listed public company in the United States and Canada which was acquired by an international conglomerate. Mr. Durkacz began his career at TD Securities on the capital markets trading floor. He holds an Honours Bachelor of Business Administration from Brock University with a major in both Accounting and Finance.
Founder, President & Executive Co-Chairman of the Board
Mr. Saeed is the “S” in FSD. Mr. Saeed started as a partner in FSD when it was just a business plan on paper. He was instrumental in raising the initial seed capital and assisted FSD’s transition into a public company. He played a key role in bringing together a team of professionals to facilitate crucial relationships and develop the Company’s business plan. Prior to founding the Company, Mr. Saeed served as President of ZZ Telecommunications Inc., a long-distance telecommunications common carrier. He has experience in international capital markets and has helped various start-ups with raising initial funding and obtaining listings on various stock exchanges. Before entering capital markets, Mr. Saeed was the founder and Chief Executive Officer of Platinum Telecommunications Inc. He has a Bachelor of Science in Mechanical Engineering.
Nathan Coyle, CPA
Chief Financial Officer
Nathan Coyle joined FSD Pharma Inc in 2020 as Corporate Controller and was appointed to the Interim Chief Financial Officer role in 2021. Mr. Coyle has 15 years of executive business experience as a finance leader in both public and private roles. With a keen eye for analytical analysis and innovative ideas he has always led his team to success.
Coyle was previously with Illinois Tool Works (NYSE:ITW) where he was a key player in restructuring the organization, shaping the growth and streamlining businesses within his industrial packaging segment. His involvement in multiple mergers and acquisitions and integrating those organizations was key to company growth. After ITW, he worked with a private organization implementing the same corporate strategies to maximize growth.
Coyle holds a Bachelor of Business Administration with honours from Brock University and is a Chartered Professional Accountant.
Co-Founder of Prismic Pharmaceuticals
Zachary Dutton joined FSD Pharma in July 2019 following the acquisition of Prismic Pharmaceuticals, where he was its CEO. Mr. Dutton is a multifunctional healthcare professional and leader with over 20 years business and entrepreneurial experience with a focus on corporate development, partnerships and strategic planning. He has broad experience within healthcare and has held senior positions in multiple sectors including prescription drugs, medical foods and dietary supplements.
Prior to founding Prismic Pharmaceuticals in 2011, Mr. Dutton held positions in several emerging companies including Primus Pharmaceuticals, a pioneer in the medical food space, where his responsibilities included business development, marketing and strategic planning and Emerge Pharma, a corporate development consulting firm he founded, where he completed multiple international licensing transactions.
He holds an Honors Bachelor of Arts from Queen’s University and received his MBA from the F.W. Olin School of Business at Babson College.
Sara May, PhD
Dr. Sara May is a Ph.D. graduate with a multidisciplinary background in plant breeding and crop genetics with over ten years’ experience designing, implementing and managing large-scale projects in the field, lab and greenhouse. She is the former President of FV Pharma, Inc., and has extensive work experience with all aspects of National, International, Provincial and Regional Legislative Acts and Regulations. Dr. May has deep domain expertise in the Medical Cannabis industry, which includes managing large scale operations, developing and implementing quality control and quality assurance methods and standard operating procedures and HACCP. Her prior experience is in the United States growing and producing high quality medical cannabis in California. She was responsible for cloning, up-keep, harvesting, processing and selling product into licensed dispensaries. Dr. May designed a specialized crop breeding program and successfully developed two new strains of cannabis.
Dr. May has co-authored ten peer-reviewed published manuscripts and is an active peer reviewer for national and international scientific journals.
Lakshmi P. Kotra, PhD
CEO of Lucid
Dr. Lakshmi Kotra, Senior Scientist at Krembil Brain Institute, University Health Network (UHN), and Professor of Medicinal Chemistry at the University of Toronto, joined FSD Pharma as CEO of its wholly-owned subsidiary, Lucid, upon completion of its acquisition of Lucid Psycheceuticals in September 2021.
Dr. Kotra received his Ph.D. in Pharmacy/Medicinal Chemistry from the University of Georgia and completed postdoctoral training at Wayne State University. He has authored/co-authored over 130 publications and delivered over 140 scientific talks internationally. Dr. Kotra is the recipient of several awards, including the Julia Levy Award from the Society of Chemical Industry (SCI) Canada in recognition of his substantial contribution to the successful commercialization of innovation in Canada in the field of biomedical science and engineering.
An academic entrepreneur, Dr. Kotra has contributed to a number of important drug discovery and development projects, including anti-HIV drugs, antibacterials, insulin, antimalarials, medical cannabis-based therapeutics, and drugs targeting multiple sclerosis. In addition to Lucid Psycheceuticals, he co-founded WinSanTor Biosciences, a San Diego, CA-based company developing treatments for peripheral neuropathies, and CannScience Innovations (Scientus Pharma), a Toronto, ON-based company focussed on medical cannabis and cannabinoids.